Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma an open-label, non-randomised, phase 1b–2 study
本文档由 7cbd86ed07 分享于2020-05-14 08:02
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma an open-label, non-randomised, phase 1b–2 study
分享：
君，已阅读到文档的结尾了呢~~